Monthly Archives: March 2017

Top 5 Clean Energy Stocks To Own For 2017

When President Donald Trump met with top airline executives Thursday, he mentioned one of his most trusted sources of information about the nation’s aviation system — his personal pilot.

“I have a pilot who’s a real expert,” he told them. “He said, ‘Sir, the equipment they’re putting on is just the wrong stuff.’ If we’re going to modernize our system we should be using the right equipment.”

“My pilot, he’s a smart guy, and he knows what’s going on,” Trump added.

Trump did not specify whom he was referring to. But it has been widely reported that John Dunkin has served as the pilot of Trump’s private Boeing 757 jet.

Dunkin has served as Trump’s personal pilot since 1989, according to a Smithsonian Channel documentary about private planes.

Donald Trump’s chief pilot, John Dunkin, on the left, and co-pilot Jay Galpin, in this 2014 file photo.

Top 5 Clean Energy Stocks To Own For 2017: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Lennar Corporation (NYSE: LEN) reported better-than-expected profit for its first quarter on Tuesday. General Mills, Inc. (NYSE: GIS) reported upbeat earnings for its fiscal third quarter, while sales missed estimates. Genesis Energy, L.P. (NYSE: GEL) disclosed that it has priced its public offering of 4 million common units for gross proceeds of $124 million. South State Corporation (NASDAQ: SSB) reported that it has increased its buyback plan from 250,000 shares to 1 million shares.

Top 5 Clean Energy Stocks To Own For 2017: Radient Technologies (RTI)

Advisors’ Opinion:

  • [By Jim Robertson]

    Shares of small cap natural compound and Cannabinoid extract stock Radient Technologies (CVE: RTI) have been taking off lately as the Company makes further progress commercializing its technology. The Company extracts natural compounds from a range of biological materials using microwave assisted processing (MAP), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield and cost. This technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source. This gives the Company a technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass’ complicated chemical system form the core of our extraction advantage.

  • [By Bryan Murphy]

    It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.

    Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.

    Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.

    To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.

    Using its patented MAP process, Radient is able to selectiv

  • [By Jim Robertson]

    Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:

Top 5 Clean Energy Stocks To Own For 2017: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha) Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss. Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate. AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101. TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday. ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday. Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday. Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday. Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share. Adobe Systems Incorporated (NASDAQ: ADBE)
  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) tumbled to the bottom of the S&P 500 today after the company’s CEO and CFO left the firm following the delay of its 10-Q last month.

    Getty Images

    Alexion Pharmaceuticals dropped 13% to $115.04 today, while the S&P 500 dipped 0.1% to 2,256.96.

    BMO’s M. Ian Somaiya offers his take on the chaos at Alexion:

    Alexion has delayed its 3Q 10-Q filing as a result of an internal investigation involving the company’s sales practices. The company continues to believe restatement of previously reported results is not required.Alexion expects filing of 3Q 10-Q in January 2017 or earlier, and 4Q/FY2016 earnings in February, when guidance is expected.

    Near-term downside may be priced in, caution on guidance. We believe the announcement of new management adds a new overhang to the stock, but also believe downside may be priced in (Alexion is down ~9% at open) and may provide an opportunity for investors to dip their toes if not their feet. We believe Alexion’s recovery will be driven by its next-generation C5 inhibitor, ALXN-1210, as every-eight-week dosing should enable Alexion to maintain 75% of the PNH market, while SubQ success, depending on dosing schedule/volume, may enable Alexion to do better. Additionally, we believe label extensions for Soliris in rMG, NMO may provide near-term growth drivers. Further upside is dependent on 30 pre-clinical assets in Alexion’s pipeline and the pace of Soliris adoption in MG. We believe the weakness may provide a unique opportunity for accumulation, with potential downside risk related to guidance from new management during 4Q/FY2016 earnings in February.

    Alexion Pharmaceuticals’ market capitalization fell to $25.8 billion today from $29.6 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) jumped to the top of the S&P 500 today after Barclays upgraded the biotech stock to Overweight from Equal Weight citing fewer macro headwinds.

    Getty Images

    Shares of Alexion Pharmaceuticals gained 5.2% to $125.59, while the S&P 500 rose 0.1%.

    Barclays analyst Geoff Meacham and team explain why they upgraded Alexion Pharmaceuticals:

    We are upgrading shares ofAlexion to Overweight and increasing our PT to $155 from $150 on an improved outlook for 2017. Specifically, we see lower FX and fewer macroeconomic risks to the core base business over the next 12 months. We also expect approval of Soliris in refractory gMG by YE17 following a planned regulatory submission in 1Q17, which could add another growth lever in early 2018 at the latest. Our upgrade is not a call on the recent 10-Q delay, which according to our discussions with management has to do with an investigation into sales practices following allegations by a former employee. We also do not anticipate major restatements of historical Soliris sales due to the investigation. Furthermore, this is not a call on Kanuma or the Synageva deal, as we have cut our Kanuma sales in our P&L and reduced its contribution in our NPV valuation. Indeed, we would expect minimal weakness inAlexion shares if the company were to take a write-down on Synageva d uring 2017, but this is not core to our investment thesis. In sum, our bullishness onAlexion shares is due to: 1) lessened FX and macroeconomic headwinds in 2017, 2) near-term Soliris growth from likely regulatory approval in refractory gMG, and 3) attractive upside potential from current levels as the pipeline including line extensions for Soliris and new assets such as 1210 mature.

    Alexion Pharmaceuticals’ market capitalization rose to $28.2 billion today from $26.8 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

  • [By David Sterman]

    Growth-oriented investors should also check out Alexion Pharmaceuticals (Nasdaq: ALXN(link is external)), which falls through the cracks between the massive well-established biotechs, and the small-cap biotechs that are still pre-revenue.

    Alexion targets rare and severe diseases, and has built a broad platform of drugs to treat them. Sales growth has never been less than 37% at any point in the past eight years, and 20% to 25% growth appears locked in over coming years as well. Analysts at UBS, who see 30% upside to their $202 price target, believe that a healthy drug pipeline provides multiple catalysts this year in the form of clinical trial updates. They suggest that shares would be worth $230 in a buyout scenario. 

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.s (NASDAQ: ALXN) short interest decreased to 4.33 million, compared to the previous level of 4.98 million. Shares closed most recently at $118.83, in a 52-week range of $110.56 to $193.45.

Top 5 Clean Energy Stocks To Own For 2017: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By David Zeiler]

    Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.

    Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.

Top 5 Clean Energy Stocks To Own For 2017: AFC Enterprises Inc.(AFCE)

Advisors’ Opinion:

  • [By AnnaLisa Kraft]

    AFC Enterprises (NASDAQ: AFCE  ) , which owns the Popeye’s Louisiana Kitchen quick- serve chain, once an undiscovered gem, has now soared 66% over the last year.

Best Safest Stocks To Buy For 2017

Many talented authors have posted about publicly listed equities trading at or near asset value with significant tax attributes, namely Net Operating Losses (NOLs), and the inherent asymmetry when an activist or new management makes a break from money losing operations to pursue transformative acquisitions. Several of the activists or lead investors, such as Becker Drapkin (EMKR, CNSI, SDOI) or Sam Zell’s Equity Group Investments (PARR and RELY), have long track records of successfully repurposing tax attribute rich companies via creative financing and transformative acquisitions. There are also some newer entrants into the space, such as KKR (OTCQB:WMIH) and Carlson Capital (OTCQB:SWKH).

The key to success in repurposing tax attribute rich companies appears to be finding an attractively priced, steady taxable income generating target, which is not easy to find at current valuations within capital markets. Indeed, some NOL rich entities sit for years without finding the desired candidate and unlocking the value of their tax assets. Simply put, investing in and unlocking value through NOL vehicles is a difficult, long-term process requiring patience.

Best Safest Stocks To Buy For 2017: ITT Corporation(ITT)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of General Electric have dropped 3.8% so far this year, with everything from its accounting to weaker margins being blamed for its weakness. Barclays’ Scott Davis and team, however, spoke with a source they call the “smartest man in the room,” who just so happens to be “nibbling” on General Electric now. They explain why and offer his views on Honeywell International (HON), Emerson Electric (EMR), and ITT (ITT) as well:

Best Safest Stocks To Buy For 2017: Semtech Corporation(SMTC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Semtech Corporation (NASDAQ: SMTC) is projected to post its quarterly earnings at $0.27 per share on revenue of $128.38 million.

    Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) is estimated to post its quarterly earnings at $0.17 per share on revenue of $190.44 million.

Best Safest Stocks To Buy For 2017: Bruker Corporation(BRKR)

Advisors’ Opinion:

  • [By Javier Hasse]

    Yet another stock experiencing a correction after the bell was Bruker Corporation (NASDAQ: BRKR), which lost 2.75 percent in after-hours, after having gained 4.5 percent during the day.

Best Safest Stocks To Buy For 2017: Tupperware Brands Corporation(TUP)

Advisors’ Opinion:

  • [By George Budwell, Rich Smith, and Neha Chamaria]

    Keeping with this theme, our Foolish contributors think that Pfizer (NYSE:PFE),Sherwin-Williams (NYSE:SHW), andTupperware Brands (NYSE:TUP)are three large-cap dividend stocks that prove beyond a doubt that boring is beautiful when it comes to creating wealth.

Best Safest Stocks To Buy For 2017: Helios and Matheson Analytics Inc(HMNY)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Helios and Matheson Analytics Inc. (Nasdaq: HMNY) is an information technology company that provides its clients predictive analytics. The company uses big data for most of its software and operates within the financial services, insurance, and healthcare industries. HMNY is up 278% YTD after it announced a strategic merger with a GPS application company, called RedZone Maps. RedZone is known for mapping crime in major cities. News of the merger sent HMNY climbing over 1,000% from $1.11 per share to $1375 per share over the course of a week. The stock has since fallen to $5.23 per share as of Monday intraday.

Best Safest Stocks To Buy For 2017: Molex Incorporated(MOLX)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Shares of electronic connector maker Molex Incorporated (MOLX) skyrocketed on Monday morning after reports that the company will be acquired by Koch Industries.

    Koch Industries has agreed to acquire Molex for a total of $7.2 billion. This deal will include all outstanding shares of the company’s Common Stock, Class A Common Stock and Class B Common Stock for $38.50 per share.

    The deal has been approved by the board of directors of both companies. Molex will continue to maintain its current management team and its current headquarters in Lisle, IL.

    Molex shares were up $9.15, or 31.17%, during Monday morning trading. The stock is up 41% YTD.

72 Winning Trades in a Row… Here's How

We just closed out our 72nd consecutive winning position…   I know that claim – 72 wins in a row – sounds far-fetched… But it's exactly what we've achieved in my trading advisory, Retirement Trader.   Not only that, but since 2010, we have been able to close 335 winners out of 356 total closed positions (a 94.1% win rate)…   All thanks to an unconventional approach to the options market.   In Retirement Trader, we sell stock options – we sell puts or covered calls. If you're not familiar with this idea, I urge you to learn more about it. You can read more here and here.   You see, lots of folks who sell options are focusing on the wrong ideas… And they'd find a lot more success if they followed my "common sense" strategy…   When most people buy or sell stock options, they focus on what the Volatility Index (the "VIX") is doing. The VIX is a widely followed indicator that measures the price of options on the broad market. It rises and falls with investor fear levels.   To see some examples of VIX behavior, check out the six-year VIX chart below. As you can see, the VIX spiked during the 2008 credit crisis. It spiked during the 2010 "Flash Crash." It spiked during the 2011 European debt scare.   When the VIX is low, options are considered cheap. When the VIX is high, options are considered expensive. So lots of folks wait to see the VIX hit an elevated level before they sell options.   But that's not what we do in Retirement Trader. Our unconventional approach doesn't require a high VIX level to make great money. In fact, most of our money has been made when the VIX was at historically low levels.   That's because our approach is based FAR MORE on great companies trading at cheap prices. Instead of focusing on what "the market" is doing, we focus on trading great companies like Coca-Cola (KO), McDonald's (MCD), and Wal-Mart (WMT). These companies have great brand names, stable sales growth, and they pay steady dividends.   Why is focusing on great companies so important? Why has it allowed us to produce such an incredible track record?   It's just basic common sense…   Great companies like Coke and McDonald's are much more stable than "hot tip" companies. They don't represent all-or-nothing bets on a specific drug… or a specific natural resource deposit.   For example, I doubt a new technology will come along and make enjoying a soda obsolete. And I doubt some new technology will come along and make cheeseburgers a thing of the past.   By focusing on companies that dominate their industries, our option trades are much more reliable than almost any kind of option trade you can imagine. By trading options around these companies, we're able to leverage our gains… but still enjoy a tremendous level of safety.   The VIX has spent the past several months below the 20 level. For a lot of folks, that means there aren't great opportunities to sell options right now. But in Retirement Trader, we've made dozens of trades on blue-chip companies like Coke and McDonald's. So far, we're averaging 16.4% annualized returns.   If you've been trading options for a while and you're not enjoying the success you'd like, consider focusing your trading on blue-chip stocks. Consider selling options on them.   The VIX will always rise and fall… But blue-chip stocks will remain stable. Trading on their brand names and stability with options has allowed us to profit on 72 consecutive closed positions. It could produce the same success for you.   Here's to our health, wealth, and a great retirement,   Dr. David Eifrig Editor's note: Today, Dave is hosting a free webinar on his unconventional option-selling technique at 1 p.m. Eastern time. He'll explain how the strategy he learned on Wall Street could safely double or triple your nest egg in a few years… And he'll walk you through a real trade you can start collecting income on right away. Click here to tune in.

China’s Xi to meet Trump in Mar-a-Lago in April

Chinese President Xi Jinping and President Donald Trump will meet for the first time on April 6-7 at the latter’s Florida resort, China’s foreign ministry announced Thursday.

The future relationship between the world’s No. 1 and No. 2 economies has been uncertain following the election of Trump, who accused China during his campaign of unfair trade practices and threatened to raise import taxes on Chinese goods and declare Beijing a currency manipulator.

It is unclear whether Trump will follow through with either threat. He is now seeking Beijing’s help in pressuring North Korea over its nuclear weapons and missiles programs.

Chinese Foreign Ministry spokesman Lu Kang told reporters that Xi would meet with Trump at Mar-a-Lago.

It is the same Florida resort where Trump hosted and played golf with Japanese Prime Minister Shinzo Abe in February.

Before arriving in the U.S., Xi will pay a state visit to Finland from April 4-6, Lu said.

safe investments

My Top Pick for income investors offers a steady 9% dividend yield plus appreciation potential, suggests Harry Domash, editor of Dividend Detective.

Originally a rural telecom, CenturyLink (CTL) has grown via acquisitions to become a major provider of broadband, voice, video, and data.

It now provides services residential and business customers over a 250,000-route-mile US fiber network and a 300,000 mile international network.

In October, CenturyLink agreed to spend $34 billion in cash and stock to acquire Level 3 Communications, a Fortune 500 company that offers local, national and global communication services to customers in 60 countries.

CenturyLink announced the Level 3 acquisition on the same day that it reported disappointing September quarter numbers.

Its share price immediately dropped more than 20 percent on concerns that it might have to take on excessive debt to finance the acquisition.

safe investments: Inc(CRM)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    The biggest positives for Microsoft Corporation in 2016 would be its triple digit (113% Azure revenue growth) cloud revenue growth and it overtaking salesforce (NYSE:CRM) to become the overall enterprise SaaS market leader. Also, Office 365 increased its customer base to 23.1 M and Dynamics CRM online seat additions, enterprise mobility customers nearly doubled year over year. Surface series revenues growing by 9% ($3.81 B in profit) in the latest quarter can also be counted as apositive. Microsoft’s commercial cloud has also touched an impressive annualized run rate of $12.1 B.

  • [By Douglas A. McIntyre]

    Twitter, which just announced earnings, is the worst off of these. Its shares are down 67% over the period to $15.58. Earnings for the past quarter showed its user base grew only 1% sequentially, a startling problem when almost all major social media businesses are booming. Monthly active users were only 319 million, up from 317 million in the previous quarter. For the quarter, revenue rose only 1% year over year to $717 million. Twitter’s chance to be bought happened several months ago when Inc. (NYSE: CRM) and several other companies showed interest. Salesforce in particular was savaged by investors for its consideration. All potential buyers disappeared.

  • [By Sreekanth Anasa]

    After dominating the public cloud,the Vmware (NYSE:VMW) partnership and the expanded alliance with Salesforce (NYSE:CRM)has put AWS on course to capture enterprise cloud market as well. Large enterprise customers are shifting their buying behavior and the world is moving fast to buy as you go infrastructure and software models. AWS partnership with VMware ensures ithas aproper hybrid cloud strategy to offer the enterprises the best of both public and private cloud.


    In the Lightning Round, Cramer was bullish on Western Digital (WDC) , Twilio (TWLO) , Adient (ADNT) , (CRM) , AT&T (T) and Verizon (VZ) .


    In his “No-Huddle Offense” segment, Cramer said there was no blaming the macro picture during the conference call of (CRM) , nor Nvidia (NDVA) or Netflix (NFLX) , or even Children’s Place.

safe investments: Apple Inc.(AAPL)

Advisors’ Opinion:


    There are now subscription-based video offerings for art films and horror, animation, comedy, competitive fishing, lots for children’s programming and every sport that rarely gets time on Disney’s (DIS) ESPN. Apple (AAPL) TV, Roku and Amazon Fire (AMZN) devices, among others, make toggling between streaming apps as easy as your internet connection can handle it. 

  • [By Virendra Singh Chauhan]

    Cupertino, California-based Apple (NASDAQ:AAPL) has recently been in the news, mostly for the right reasons. Barring the chatter regarding its appeal against the European Union’s $14B tax charge, Apple is enjoying a lot of positive buzz with respect to its next iPhone launch. The result has been positive commentary from multiple wall street analysts and a rising stock price. Apple stock price is up over 18% in the year-to-date, outperforming the Nasdaq Composite (INDEX:COMPX) as well as S&P 500 (INDEX:SPAL) in the same time frame. Apple stock has rallied 51% since the May 2016 lows, closing the last trading session at a price of $136.7 per share. The AAPL rally has, so far, been fuelled in a large part by a stronger-than-expected performance of the iPhone segment in the holiday quarter and the rapidly growing Apple services segment. However, we think the stock could be headed further higher driven by a growing bullishness among investors and potential for an iPhone 8-d riven super-cycle.

  • [By Yasin Ebrahim]

    Recent sales figuresseem to suggest that the enthusiasm for Apple (NSDQ:AAPL)products have waned as Microsofts surface has toppled Apples Macbook sales during November. More importantly and worrisome is the slump in iPhone unit sales, falling for the first time since the device hit the market in 2007.

  • [By Brian Mathews]

     Apple Inc. (NASDAQ: AAPL) is one of the most recognized brands and companies in the world. It is the largest company by market capitalization, with over $665 billion. Apple continually surprises investors with its constant stream of new products and ability to retain its customer base. The same is expected in 2016, with Apple potentially releasing a smaller iPhone and a new iPhone 7 model. Apple also continues to diversify from its phone segment by further developing the Apple Pay, Apple Watch and Apple TV markets. Apple has had a fairly volatile year in 2015, but expect the stock to appreciate next year with most analysts giving it a price target of $140.

  • [By Evan Niu, CFA]

    Expectations for the 2017 iPhone are running high, given the fact that it will be the 10th-generation of Apple’s (NASDAQ:AAPL) most important product. As always, a steady stream of supply-chain leaks are stoking speculation as to what features the Mac maker may or may not include. The most expensive feature-packed model may even set customers back over $1,000. Today’s rumor comes from the notoriously hit-or-miss DigiTimes, which says that in addition to an OLED display and wireless charging, the device will also include iris-scanning technology.

safe investments: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Yet some solid individual stock gains also helped lift investors’ moods, and Sears Holdings (NASDAQ:SHLD), National Beverage (NASDAQ:FIZZ), and JetBlue Airways (NASDAQ:JBLU) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Demitrios Kalogeropoulos]

    Tailored Brands (NYSE:TLRD) and National Beverage (NASDAQ:FIZZ) were two of the biggest individual stock movers on Thursday.

    Winners and losers

    Shares of formal clothing specialist Tailored Brands dove 32% after the companyposted surprisingly weak fiscal fourth-quarter earnings results. Sales fell 3.9% to $793 million, while consensus estimates were targeting a more modest decline to $805 million.

safe investments: Arrow Electronics, Inc.(ARW)

Advisors’ Opinion:

  • [By Brian Mathews]

    Arrow Electronics Inc. (NYSE: ARW) is one of the world’s largest distributors of electric components and computer products. During 2015, ARW struggled primarily due to unfavorable currency fluctuations. However, the company has been seasonal toward the end of the year, especially in Europe, and is expected to carry that positive momentum into the New Year. Arrow has packaged its core products and value-added services into a comprehensive solution that lowers the cost base over a product’s lifetime, yet adds higher client engagement. With a diversified product line and successful current strategy, Arrow is well positioned to grow to a target price of $65.

safe investments: TravelCenters of America LLC(TA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, energy shares dipped by 0.70 percent. Meanwhile, top losers in the sector included TravelCenters of America LLC (NYSE: TA), down 18 percent, and Alon USA Energy, Inc. (NYSE: ALJ), down 8 percent.